164 related articles for article (PubMed ID: 10599635)
1. Abnormal uroporphyrin levels in chronic hepatitis C virus infection.
Martinelli AL; Villanova MG; Roselino AM; Figueiredo JF; Passos AD; Covas DT; Zucoloto S
J Clin Gastroenterol; 1999 Dec; 29(4):327-31. PubMed ID: 10599635
[TBL] [Abstract][Full Text] [Related]
2. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
[TBL] [Abstract][Full Text] [Related]
3. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
[TBL] [Abstract][Full Text] [Related]
4. Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces.
Gibson PR; Grant J; Cronin V; Blake D; Ratnaike S
J Gastroenterol Hepatol; 2000 Feb; 15(2):192-201. PubMed ID: 10735544
[TBL] [Abstract][Full Text] [Related]
5. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
[TBL] [Abstract][Full Text] [Related]
6. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
[TBL] [Abstract][Full Text] [Related]
7. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
To-Figueras J; Ozalla D; Mateu CH
Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438
[TBL] [Abstract][Full Text] [Related]
8. Abnormal chromatographic patterns of porphyrins in urine.
Nuttall KL
Ann Clin Lab Sci; 2001 Jul; 31(3):259-64. PubMed ID: 11508829
[TBL] [Abstract][Full Text] [Related]
9. The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland.
Hussain I; Hepburn NC; Jones A; O'Rourke K; Hayes PC
Clin Exp Dermatol; 1996 Jul; 21(4):283-5. PubMed ID: 8959900
[TBL] [Abstract][Full Text] [Related]
10. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
[TBL] [Abstract][Full Text] [Related]
11. [Porphyrin excretion in patients with chronic hepatitis C virus infection].
Armas-Merino R; Wolff C; Parraguez A; Soto JR
Rev Med Chil; 1997 Mar; 125(3):279-82. PubMed ID: 9460263
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin abnormalities in acquired immunodeficiency syndrome.
O'Connor WJ; Murphy GM; Darby C; Fogarty J; Mulcahy F; O'Moore R; Barnes L
Arch Dermatol; 1996 Dec; 132(12):1443-7. PubMed ID: 8961872
[TBL] [Abstract][Full Text] [Related]
13. [Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus].
Wolff C; Stella AM; Armas R; Parraguez A; Silva H; Batlle AM
Rev Med Chil; 1998 Mar; 126(3):245-50. PubMed ID: 9674292
[TBL] [Abstract][Full Text] [Related]
14. Spot urine porphyrins/creatinine ratio profile of healthy Brazilian individuals adjusted for personal habits.
Alves AN; Sumita NM; Burattini MN; Della Rosa HV
Braz J Med Biol Res; 2009 Aug; 42(8):700-6. PubMed ID: 19448892
[TBL] [Abstract][Full Text] [Related]
15. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
16. Plasma porphyrins in chronic renal failure.
Gebril M; Weinkove C; Ead R; McDonald K; Morton R
Nephron; 1990; 55(2):159-63. PubMed ID: 2362629
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C and porphyria cutanea tarda.
English JC; Peake MF; Becker LE
Cutis; 1996 Jun; 57(6):404-8. PubMed ID: 8804842
[TBL] [Abstract][Full Text] [Related]
18. [Sclerodermatous changes in porphyria cutanea tarda: six cases].
Khayat R; Dupuy A; Pansé I; Bagot M; Cordoliani F
Ann Dermatol Venereol; 2013 Oct; 140(10):589-97. PubMed ID: 24090888
[TBL] [Abstract][Full Text] [Related]
19. Pustular Skin Lesions.
Awad MT; Banifadel M
Gastroenterology; 2021 Feb; 160(3):675-676. PubMed ID: 32569774
[No Abstract] [Full Text] [Related]
20. Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature.
Cassiman D; Vannoote J; Roelandts R; Libbrecht L; Roskams T; Van den Oord J; Fevery J; Garmyn M; Nevens F
Acta Gastroenterol Belg; 2008; 71(2):237-42. PubMed ID: 18720935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
